Topic: Manufacturing jobs
For the second time in three weeks, the GlaxoSmithKline and Pfizer consumer joint venture has named a plant it will divest to raise cash for its JV.
North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina.
The end is near for a GlaxoSmithKline OTC plant in Pennsylvania and its 260 employees. In fact, it has a date.
AstraZeneca employs more than 1,000 people in Australia and New Zealand, and again its ranks will grow.
After years of negotiation and work stoppage threats, Pfizer is backing off on plans to overhaul pension plans at some of its Irish plants.
Merck's expansion of Gardasil production in Virginia and now in North Carolina means $1.68 billion in investments and 525 new jobs.
A manufacturing facility that Novartis discarded because of declining generics sales is getting a new life producing CBD products.
Boehringer Ingelheim has invested €225 million on inhaler production with a new plant in Spain and expanded lines in Germany.
KriGen Pharmaceuticals plans to build a $7 million facility in Lillington, North Carolina.
GlaxoSmithKline will unload an API plant to Thermo Fisher Scientific for €90 million. The U.S. company says it is glad to get it.